Role of brain natriuretic peptide in the diagnosis and management of heart failure: Current concepts
- 1 October 2002
- journal article
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 8 (5) , 288-299
- https://doi.org/10.1054/jcaf.2002.127769a
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure)Circulation, 2001
- Vascular actions of brain natriuretic peptide: modulation by atherosclerosis and neutral endopeptidase inhibitionJournal of the American College of Cardiology, 2000
- Natriuretic peptides: Physiology, therapeutic potential, and risk stratification in ischemic heart diseaseAmerican Heart Journal, 1998
- Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failureJournal of Cardiac Failure, 1998
- Mechanisms and management of renal dysfunction in heart failureCurrent Opinion in Cardiology, 1997
- The natriuretic-peptide familyThe Lancet, 1997
- Increased Human Brain Natriuretic Peptide in Congestive Heart FailureNew England Journal of Medicine, 1990
- Congestive cardiac failure: central role of the arterial blood pressure.Heart, 1987
- Effect of atrial peptides on aldosterone production.Journal of Clinical Investigation, 1985
- Effects of synthetic atrial natriuretic factor on renal function and renin releaseAmerican Journal of Physiology-Renal Physiology, 1984